|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Investments, at fair value | ||||||||||||
| Non-controlled non-affiliated investments (cost of $944,000 and $870,675, respectively) | ||||||||||||
| Non-controlled non-affiliated | ||||||||||||
| Total non-controlled non-affiliated investments (cost of $944,000 and $870,675, respectively) | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Restricted cash and cash equivalents | ||||||||||||
| Interest receivable | ||||||||||||
| Interest and dividend receivable | ||||||||||||
| Receivable from unsettled transactions | ||||||||||||
| Deferred offering costs | ||||||||||||
| Unrealized appreciation on foreign currency forward contract | ||||||||||||
| Other assets | ||||||||||||
| Total assets | ||||||||||||
| Liabilities | ||||||||||||
| Debt (net of deferred financing costs of $6,163 and $6,873, respectively) | ||||||||||||
| Interest and other debt financing costs payable | ||||||||||||
| Distribution payable | ||||||||||||
| Accrued expenses and other liabilities | ||||||||||||
| Directors’ fees payable | ||||||||||||
| Payable for investments purchased | ||||||||||||
| Management fees payable | ||||||||||||
| Due to administrator | ||||||||||||
| Unrealized depreciation on foreign currency forward contracts | ||||||||||||
| Subscriptions received in advance | ||||||||||||
| Accrued professional fees | ||||||||||||
| Total liabilities | ||||||||||||
| Net assets | ||||||||||||
| Common stock, par value $0.01 per share (300,000,000 shares authorized, 19,165,828 and 17,187,406 shares issued and outstanding, respectively) | ||||||||||||
| Paid-in capital in excess of par value | ||||||||||||
| Accumulated earnings/(loss) | ||||||||||||
| Class I Shares | ||||||||||||
| Class S Shares | ||||||||||||
| Class D Shares | ||||||||||||
| Total net assets | ||||||||||||
| Common Shares outstanding ($0.01 par value, 100,000,000 shares authorized) | ||||||||||||
| Class I Shares | ||||||||||||
| Class S Shares | ||||||||||||
| Class D Shares | ||||||||||||
| Total common Shares outstanding ($0.01 par value, 100,000,000 shares authorized) | ||||||||||||
| Net asset value per share | ||||||||||||
| Class I Shares | ||||||||||||
| Class S Shares | ||||||||||||
| Class D Shares | ||||||||||||
| Total net asset value per share | ||||||||||||
| Total liabilities and net assets |
Loading...